Intellipharmaceutics International Buy Hold or Sell Recommendation
| IPCIFDelisted Stock | USD 0.04 0.00 0.00% |
Assuming the 90 days horizon and your highly speculative risk level, our recommendation regarding Intellipharmaceutics International is 'Not Rated'. Macroaxis provides Intellipharmaceutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IPCIF positions.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. Note, we conduct extensive research on individual companies such as Intellipharmaceutics and provide practical buy, sell, or hold advice based on investors' constraints. Intellipharmaceutics International. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Intellipharmaceutics |
Execute Intellipharmaceutics Buy or Sell Advice
The Intellipharmaceutics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Intellipharmaceutics International. Macroaxis does not own or have any residual interests in Intellipharmaceutics International or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Intellipharmaceutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Intellipharmaceutics Trading Alerts and Improvement Suggestions
| Intellipharmaceutics is not yet fully synchronised with the market data | |
| Intellipharmaceutics has some characteristics of a very speculative penny stock | |
| Intellipharmaceutics has a very high chance of going through financial distress in the upcoming years | |
| Intellipharmaceutics has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Intellipharmaceutics International has accumulated 2.01 M in total debt with debt to equity ratio (D/E) of 165.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intellipharmaceutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Intellipharmaceutics until it has trouble settling it off, either with new capital or with free cash flow. So, Intellipharmaceutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intellipharmaceutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intellipharmaceutics to invest in growth at high rates of return. When we think about Intellipharmaceutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (5.15 M) with profit before overhead, payroll, taxes, and interest of 1.4 M. | |
| Intellipharmaceutics International has accumulated about 79.65 K in cash with (2.46 M) of positive cash flow from operations. |
Intellipharmaceutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Intellipharmaceutics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Intellipharmaceutics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Intellipharmaceutics Returns Distribution Density
The distribution of Intellipharmaceutics' historical returns is an attempt to chart the uncertainty of Intellipharmaceutics' future price movements. The chart of the probability distribution of Intellipharmaceutics daily returns describes the distribution of returns around its average expected value. We use Intellipharmaceutics International price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Intellipharmaceutics returns is essential to provide solid investment advice for Intellipharmaceutics.
| Mean Return | 13.50 | Value At Risk | -50 | Potential Upside | 100.00 | Standard Deviation | 51.90 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Intellipharmaceutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Intellipharmaceutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Intellipharmaceutics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Intellipharmaceutics Buy or Sell Advice
When is the right time to buy or sell Intellipharmaceutics International? Buying financial instruments such as Intellipharmaceutics OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Intellipharmaceutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cigarettes Thematic Idea Now
Cigarettes
Tobacco makers and distributors across globe. The Cigarettes theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |